PierianDX, ArcherDX Partner Up
News Jul 20, 2016
ArcherDX and PierianDx announced a co-marketing and licensing agreements that will provide enhanced NGS testing capabilities to clinical labs. Under the terms of the agreement, PierianDx will integrate Archer® targeted NGS testing pipelines into the PierianDx Clinical Genomicist Workspace™ (CGW).
Archer’s FusionPlex® and VariantPlex™ target enrichment assays, coupled with its bioinformatics software, Archer Analysis, report known and novel gene fusions, CNVs, point mutations and relative expression levels from NGS libraries.
“Integrating Archer Analysis and the corresponding target enrichment assays into CGW enables PierianDx’s partner laboratories to offer the most comprehensive, clinically relevant results to oncologists,” said PierianDx CEO Ted Briscoe. “Archer’s FusionPlex and VariantPlex assays provide more granular details about CNVs, fusions and point mutations in their patient samples, providing enhanced NGS testing capability to clinical labs seeking a complete solution for their personalized medicine programs.”
“NGS data contains only the primary sequencing information for downstream analysis, and ultimately, reporting of clinically relevant variants in a scalable manner is the desired end result,” said Todd Pollard, Vice President of Global Sales and Support at ArcherDX. “Partnering with PierianDx enables laboratories who use the Archer assays to seamlessly process clinical cases from accessioning to final report using PierianDx’s comprehensive workflow, curated knowledgebase, and partner-sharing network.”
Shire, Microsoft and EURORDIS Form Global Commission to Accelerate Rare Disease DiagnosisNews
The alliance aims to shorten the often multi-year journey that patients and families endure before being diagnosed with a rare disease.READ MORE
Susan Audino Joins CloudLIMS’ Scientific Advisory BoardNews
Dr. Susan Audino, Chair of the Cannabis Working Group at AOAC International, has joined the Scientific Advisory Board at CloudLIMS, which specialises in data management solutions for cannabis testing laboratories.READ MORE
RNA That Helps Grow Blood Vessels Could Aid Heart Disease ResearchNews
STEEL, a noncoding RNA, acts on genes to stimulate produce of blood vessels, a finding which could advance efforts to combat heart disease.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018